Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01189851 · ClinicalTrials.gov registry record · NA
Intraoperative Radiotherapy for Early Stage Breast Cancer
A NA study, sponsored by Hoag Memorial Hospital Presbyterian.
- Completed
- Registry status
- NA
- Development phase
- 200
- Enrollment target
NCT01189851 is a NA study that has completed, run by Hoag Memorial Hospital Presbyterian. The registered enrollment target is 200 participants.
The verdict
NCT01189851, a NA study, has completed, sponsored by Hoag Memorial Hospital Presbyterian.
- COMPLETED
- Registry status
- NA
- Development phase
- 200 participants
- Enrollment target
Study Summary
Up to 200 patients with biopsy proven early stage breast cancer selecting Wide Local Excision (WLE) will undergo mammography, ultrasound (of affected breast and ipsilateral axilla) and contrast enhanced-magnetic resonance imaging (CE-MRI) of the affected breast to evaluate the extent of disease.
Interventions
- DEVICE Intraoperative Radiotherapy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 200 participants |
| Start Date | 2010-06 |
| Est. Completion | 2023-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01189851
The ClinicalTrials.gov registry entry for NCT01189851 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 200 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Hoag Memorial Hospital Presbyterian, which has 20 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Intraoperative Radiotherapy is the first listed.
NCT01189851 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01189851 about?
NCT01189851 is a clinical study titled "Intraoperative Radiotherapy for Early Stage Breast Cancer". Up to 200 patients with biopsy proven early stage breast cancer selecting Wide Local Excision (WLE) will undergo mammography, ultrasound (of affected breast and ipsilateral axilla) and contrast enhanced-magnetic resonance imaging (CE-MRI) of the affected breast to evaluate the extent of disease.
What is the current status of trial NCT01189851?
This trial is currently completed. It is a NA study. The enrollment target is 200 participants. The study started on 2010-06. Estimated completion is 2023-12.
What interventions are being tested in trial NCT01189851?
The interventions under investigation include: Intraoperative Radiotherapy (DEVICE).
Who is sponsoring clinical trial NCT01189851?
This trial is sponsored by Hoag Memorial Hospital Presbyterian, which has 20 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.